脱发区:当前的治疗方法和新的方向
Dante Dahabreh1, Seungyeon Jung1,2, Yael Renert-Yuval3
1Laboratory of Inflammatory Skin Diseases, Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 E. 98th Street, New York, NY, 10029, USA.
American journal of clinical dermatology
|August 22, 2023
概括
脱发症,一种自身免疫性脱发症,越来越多地被理解,新的研究确定了超出T-helper 1的免疫路径. 向疗法,包括简氏激酶 (JAK) 抑制剂,正在改变严重病例的治疗方法.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 大发性脱发症是一种无痕的自身免疫性疾病,导致慢性毛囊炎炎症.
- 临床表现范围从斑块性脱发到全身脱发.
- 目前的治疗包括轻度病例的类固醇和严重病例的免疫抑制剂,具有有限的基于证据的范式.
研究的目的:
- 审查当前的脱发区治疗方法,包括疗效,安全性和耐受性.
- 为了提供一个概述的新兴疗法彻底改变了脱发区的管理.
- 要突出了解脱发区病变的近期进展.
主要方法:
- 审查当前关于脱发区治疗的文献.
- 对最近的临床试验和FDA批准的分析.
- 基于免疫学见解的新兴治疗点的检查.
主要成果:
- 扩大了对T-辅助剂1/干扰素偏差的传统观点; Th2,IL-9,IL-23和IL-32通路都与此有关.
- 雅努斯激酶 (JAK) 抑制剂 (巴里西提尼布,里特利西提尼布) 已获得FDA批准,并且对严重的脱发有多样性.
- 新型向药物正在临床试验中,这表明治疗领域的潜在转变.
结论:
- 人们对大发性脱毛病的理解已经进化,揭示了多种免疫媒介.
- 向疗法,特别是JAK抑制剂,在治疗严重脱发症方面取得了重大进展.
- 新兴的治疗方法为患有这种具有挑战性的自身免疫性疾病的患者提供了新的希望和改善的结果.
相关概念视频
Accessory Structures of the Skin: Hair Growth and Types
1.5K
Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...
1.5K
Alzheimer's Disease: Treatment
213
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
213
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Open Angle Glaucoma: Treatment
477
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
477
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342


